Last news
Ascenda and Galileo Financial Technologies Collaborate to Elevate Card Loyalty Programs

Ascenda and Galileo Financial Technologies Collaborate to Elevate Card Loyalty Programs

Partnership combines Galileo's technology platform and Ascenda's loyalty expertise to simplify and power card loyalty programs NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Ascenda, the industry leader in loyalty-as-a-service, has partnered with Galileo...

Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication

Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication

Axiad's PKI-based authentication enables scalability and flexibility in large-scale enterprise environments, elevates user experience and streamlines user access control SAN ANTONIO, Feb. 25, 2025 /PRNewswire/ -- Frost & Sullivan recently...

New Research Shows Surging Consumer Demand for AI-Banking Services, According to Personetics Global Survey

New Research Shows Surging Consumer Demand for AI-Banking Services, According to Personetics Global Survey

A survey of 2,000 bank customers reveals that 84% are likely to switch banks to access services that help them reach their financial goals NEW YORK, Feb. 25, 2025 /PRNewswire/ -- Personetics, the company that transforms how banks build and monetize...

Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma

Kangpu Biopharmaceuticals Received IND Approval from NMPA for KPG-818 to Treat Relapsed/Refractory Multiple Myeloma

HEFEI, China, Feb. 25, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. ("Kangpu") today announced that the Company has received IND approval from the CDE (Center for Drug Evaluation) of China National Medical Products Administration (NMPA) for...

CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,...

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Zealand, with interim results expected by 2026 Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding support from...

RoboSense Achieves Milestone with Production and Delivery of Its 1 Millionth LiDAR

RoboSense Achieves Milestone with Production and Delivery of Its 1 Millionth LiDAR

SHENZHEN, China, Feb. 25, 2025 /PRNewswire/ -- On February 21, RoboSense (2498.HK), an AI-driven robotics technology company that supplies industry-leading incremental components and solutions for the robotics market, held a ceremony in Shenzhen to...

Cedro Participações signs concession contract for the Port of Itaguaí at an event with President Lula and Minister Silvio Costa Filho

Cedro Participações signs concession contract for the Port of Itaguaí at an event with President Lula and Minister Silvio Costa Filho

The company will be the first 100% Brazilian mining company to verticalize its operations and intends to invest R$3.6 billion in the project MINAS GERAIS, Brazil, Feb. 25, 2025 /PRNewswire/ -- Last Friday (21), Cedro Participações signed the...

1 ... 989 990 991 992 993 994 995 996 997 ... 2867
menu
menu